Physician profile
Andrew A Tarleton
NPI 1497912729
$12,753.43
in general payments reported to CMS, 2019-2025
8 companies · $708 in 2025
The $708 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,479 · 2020: $3,508 · 2021: $1,458 · 2022: $1,039 · 2023: $1,447 · 2024: $1,116 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,270.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $9,050.68 | 2019-2023 | Simplify Cervical Artificial Disc, Acp, Tlx |
| Globus Medical, INC. | $1,365.99 | 2024-2025 | Allocate, Allocate, Alif |
| Stryker Corporation | $945.09 | 2019-2021 | |
| Djo, LLC | $607.79 | 2019-2025 | Cmf |
| 4web, INC. | $318.85 | 2020-2024 | Spine Truss System |
| Orthofix Medical, INC. | $287.88 | 2022-2025 | Spinal-Stim, Spinal-Stim |
| Horizon Therapeutics Plc | $160.62 | 2019-2020 | |
| Depuy Synthes Sales INC. | $16.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Tarleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.